NCT00599105View on ClinicalTrials.gov

Angiogenesis in Early Breast Cancer for Prognosis Prediction

NACompletedINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Breast Lesions
Interventions
PROCEDURE

magnetic resonance imaging

MRI contrast agent, 0.1 mmol/kg

Trial Locations (1)

92697

Center for Functional Onco-Imaging, University of California, Irvine

All Listed Sponsors
lead

University of California, Irvine

OTHER

NCT00599105 - Angiogenesis in Early Breast Cancer for Prognosis Prediction | Biotech Hunter | Biotech Hunter